ArticleOncogene2019

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis.

Brittelle E Kessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.